Institutional members access full text with Ovid®

Share this article on:

Treatment of acute coronary syndrome: Part 2: ST-segment elevation myocardial infarction

Trost, Jeffrey C. MD, FACC; Lange, Richard A. MD, FACC

doi: 10.1097/CCM.0b013e31824e18c2
Concise Definitive Review

Objective: Familiarize clinicians with recent information regarding the diagnosis and treatment of ST-segment elevation myocardial infarction.

Data Sources: PubMed search and review of relevant medical literature.

Summary: Definition, pathophysiology, clinical presentation, diagnosis, and treatment of ST-segment elevation myocardial infarction are reviewed.

Conclusions: Patients with ST-segment elevation myocardial infarction benefit from prompt reperfusion therapy. Adjunctive antianginal, antiplatelet, antithrombotic, beta blocker, angiotensin-converting enzyme inhibitor, and statin agents minimize ongoing cardiac ischemia, prevent thrombus propagation, and reduce the risk of recurrent cardiovascular events.

From the Johns Hopkins School of Medicine (JCT), Baltimore, MD, and the University of Texas Health Science Center at San Antonio (RAL), San Antonio, TX.

The authors have not disclosed any potential conflicts of interest.

For information regarding this article, E-mail: jtrost2@jhmi.edu

© 2012 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins